Interpreting quality of life data: should we listen to the patient or the clinician?

被引：11

作者：

Juniper, EF ^{[1
]}

机构：

[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada

来源：

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2003年 / 91卷 / 02期

关键词：

D O I：

10.1016/S1081-1206(10)62161-8

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：115 / 116

页数：2

共 6 条

[1] Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate [J].

Juniper, EF ;

Price, DB ;

Stampone, PA ;

Creemers, JPHM ;

Mol, SJM ;

Fireman, P .

CHEST, 2002, 121 (06) :1824-1832

[2] DETERMINING A MINIMAL IMPORTANT CHANGE IN A DISEASE-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE [J].

JUNIPER, EF ;

GUYATT, GH ;

WILLAN, A ;

GRIFFITH, LE .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (01) :81-87

[3] Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma [J].

Juniper, EF ;

Norman, GR ;

Cox, FM ;

Roberts, JN .

EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (01) :38-44

[4]

Mazur DJ., 2001, SHARED DECISION MAKI

[5]

*NIH, 2002, GLOBAL INITIATIVE AS

[6] Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report [J].

Wyrwich, KW ;

Nelson, HS ;

Tierney, WM ;

Babu, AN ;

Kroenke, K ;

Wolinsky, FD .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) :148-153

← 1 →